Improving patients‘ lives through an innovative approach to medical cannabis
GROW Germany is part of the GROW Group, an international biopharmaceutical company specializing in cannabis-based medicines. Our goal is to sustainably improve the lives of patients through innovative therapeutic approaches.
We work closely with physicians, pharmacists, and healthcare professionals to explore new paths in cannabinoid therapy. Our mission is to create a world where life-changing cannabis medicines are obtainable to every patient who will benefit from them. We have a focus on developing modern and effective treatment options for patients with chronic or debilitating conditions.
Improving Access
To ensure patients receive the best possible care, we support access to high‑quality medical cannabis products. At the same time, we are committed globally to improving the affordability of such therapies for healthcare systems and patients.
Strong Partnerships
GROW Germany collaborates with licensed pharmaceutical companies, making a significant contribution to the GROW Group’s vision: reaching as many patients as possible and enhancing their quality of life.
Research and Development
We believe progress comes through collaboration. That’s why we actively seek partners for scientific projects and continue to invest in research and data generation. Our goal is to:
– Identify unique cannabis flower varieties
– Develop new extract formulations tailored to patient needs
– Create innovative delivery forms that benefit all patient groups
Our Commitment
GROW Germany strives to be one of the most innovative companies in the field of medical cannabis in Europe. We focus on long-term partnerships and collective efforts to advance the development of cannabis-based medicines.
Because every patient matters.
